Enovis (ENOV) Change in Accured Expenses (2010 - 2011)
Enovis (ENOV) reported Change in Accured Expenses of -$9.4 million for Q4 2011, down 159.9% year-over-year from $15.7 million in Q4 2010, and down 1109.98% on a QoQ basis from $932000.0 in Q3 2011.
Enovis (ENOV) has 2 years of Change in Accured Expenses data on file, last reported at -$9.4 million in Q4 2011.
- Quarterly Change in Accured Expenses fell 159.9% year-over-year to -$9.4 million in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $16.0 million (changed N/A YoY) and the FY2011 annual result came in at -$10.9 million, down 150.1% from the prior year.
- Change in Accured Expenses retreated to -$9.4 million in Q4 2011 per ENOV's latest filing, from $932000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $15.7 million in Q4 2010 and bottomed at -$9.4 million in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -9.41 Mn |
| Dec 31, 2011 | -9.41 Mn |
| Sep 30, 2011 | 932,000.00 |
| Sep 30, 2011 | 932,000.00 |
| Dec 31, 2010 | 15.72 Mn |
| Dec 31, 2010 | 15.72 Mn |
| Oct 1, 2010 | 8.74 Mn |
| Oct 1, 2010 | 8.74 Mn |